FDA pauses Regenxbio gene therapy trial again due to safety concerns - STAT

FDA pauses Regenxbio gene therapy trial again due to safety concerns - STAT
Business

Listen to this article

0%

The Food and Drug Administration has again paused trials for Regenxbios gene therapy for a rare childhood brain disorder, after small masses were found on the spines of five patients, the company sai… [+699 chars]

Leave A Comment

Comments are moderated and may take time to appear.

Comments

No comments yet. Be the first to comment!

Stay Connected